glp-1 receptor agonist drug names Agonists top glp 1 drug companies
Description
Diabetes Care 41(12):25522559
2015 Jul 2;373(1):11-22
Sato, S
The availability of Novo Nordisk's Rybelsus which is an oral semaglutide with minimal gastrointestinal side effects and increased acceptability in Australia is expanding the market growth
However this seems to be species specific: BAT activation is not observed in humans with a glucagon infusion (55)
Patients may also receive training on injection techniques to ensure they can self-administer the medication safely and effectively
